Target intelligence / Profile preview

Capsular polysaccharide and surface protein of Neisseria meningitidis

Molecular classification
Polysaccharide antigen (capsule), Bacterial surface protein, Adhesin, Other (for diverse outer membrane proteins)
01

Overview

Capsular polysaccharide and surface proteins of Neisseria meningitidis constitute the major virulence factors that facilitate bacterial survival in the human host and are the primary targets of approved and experimental vaccines[6][7][2]. The capsular polysaccharide, defining serogroups (A, B, C, W, Y, X), confers protection against complement-mediated killing and is a key antigen in conjugate and polysaccharide vaccines[6][7]. Surface proteins, such as Neisserial surface protein A (NspA), factor H binding protein (fHbp), NadA, PorA, Opa, and Opc, mediate adherence, immune evasion (e.g., by binding factor H, inhibiting complement as with fHbp and NspA), iron acquisition, and biofilm formation[3][4][2][5]. Many surface-exposed proteins are the basis of newer vaccines, especially for serogroup B, which is poorly immunogenic to polysaccharide-based approaches[4][3]. The virulence and vaccine relevance of these structures make them therapeutic and diagnostic targets; however, the term itself is overly broad and lacks specificity, as it encompasses multiple distinct molecular entities (e.g., capsule and numerous proteins), each with unique immunological and molecular characteristics. Therefore, "Capsular polysaccharides and surface proteins of Neisseria meningitidis" is not a singular target but groups together multiple molecules of different classes[6][2]. **Note:** - The target as stated is overly broad, encompassing *both* capsular polysaccharide (a complex sugar polymer) and multiple unrelated surface proteins (various outer membrane proteins, adhesins, and immune modulators), each of which may be considered a molecular target on its own. For structured biomedical purposes, select specific molecules (e.g., "Neisseria meningitidis serogroup B capsular polysaccharide" or "Factor H binding protein") as canonical targets rather than the whole collection[6][3][2]. - If you need structured information on individual entities, request for one surface protein (e.g., NspA, fHbp) or "capsular polysaccharide" for a given serogroup.

Other names
Meningococcal capsuleMeningococcal surface proteinsNspAfHbpNadAPorAOpaPilEOpc
02

Mechanism of action

Induction of protective antibodies (vaccines), Blocking adhesion (antibodies), Complement activation (antibody-mediated lysis)

03

Biological functions

Immune evasionAdhesion to host cellsInvasionIron acquisitionBiofilm formation
04

Disease associations

Infection (meningococcal meningitis and septicemia)
05

Safety considerations

Antigenic variability leading to escape from immunityPotential autoimmunity (polysaccharide mimicry)Hyporesponsiveness in infants to polysaccharide vaccines
06

Interacting drugs

Meningococcal polysaccharide vaccines

2 more in the full profile.

07

Biomarkers

Presence of capsule-specific antibodies (for efficacy)Surface protein antibody titers (for efficacy)

Beyond the preview

Go deeper on Capsular polysaccharide and surface protein of Neisseria meningitidis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capsular polysaccharide and surface protein of Neisseria meningitidis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call